what is known already: The human endometrial transcriptome has been extensively investigated in the last decade resulting in the development of a new diagnostic test based on the transcriptomic signature of the window of implantation (WOI). Much less is known about the proteomics derived from the transcripts present during the WOI. study design, size, and duration: This study was a basic proteomic analysis of human endometrial biopsies taken from twelve IVF patients.
Introduction
The human endometrium is a highly specialized, hormonally regulated organ which is not receptive to the embryo during the major part of the menstrual cycle. The acquisition of endometrial receptivity is limited to a very short period in which endometrial tissue acquires a functional and transient ovarian steroid hormone-dependent status, which allows blastocyst adhesion. This period is commonly named the window of implantation (WOI), lasts between 12 h and 2 days, and varies from patient to patient . The luminal epithelium acquires the receptive phenotype by acquiring specific structural and functional changes related to cytoskeletal reorganization (Martín et al., 2000; Thie and Denker, 2002) which is induced by a specific genomic signature (Díaz-Gimeno et al., 2011 . In the search for an objective diagnostic tool, our laboratory designed the endometrial receptivity array (ERA) which consists of a customized array containing 238 genes expressed during the WOI, coupled to a computational predictor able to identify the receptivity status regardless of the histological appearance of the endometrium (Díaz-Gimeno et al., 2011) . The accuracy of the ERA test has been demonstrated to be superior to endometrial histological examination, and the results were reproducible in the same patients up to 29-40 months after the first test .
Since proteins translated from transcribed genes are the final effectors in tissues, we wondered if the WOI transcriptomic signature had an identifiable proteomic counterpart. The proteomics of the human endometrium has already been addressed in different papers (DeSouza et al., 2005; Dominguez et al., 2009; Parmar et al., 2009; Hannan et al., 2010) comparing endometrial samples obtained throughout the menstrual cycle. To compare and quantify the total expression profiles of complex protein mixtures, the most widely used method is currently differential in-gel electrophoresis (DIGE; Unlu et al., 1997) , which is based on prior electrophoretic labelling of samples with spectrally different fluorescent dyes (Cy3 or Cy5), using a third spectrally different fluorescent dye (Cy2) to label an internal standard sample comprising equal amounts of all the biological samples in the experiment (Alban et al., 2003; Knowles et al., 2003) .
In this study, we aimed to gain insights into the proteomic signature of endometrial receptivity by using DIGE and mass spectrometry to analyse endometrial samples already diagnosed as receptive (R) or non-receptive (NR) by an established transcriptomic diagnostic test (the ERA) and which functionally resulted in a pregnancy or not.
Materials and Methods

Study design
Human endometrial samples were diagnosed as receptive (R) or nonreceptive (NR) according to their transcriptomic signature using the ERA test. All recruited patients had had IVF failures of different origins and a high average age. Twelve of these patients (six R and six NR) were used for the proteomic study (Table I) .
In patients diagnosed as R (n ¼ 6), embryos were transferred accordingly and pregnancy was achieved with the exception of one case (see Table I ). In those diagnosed as NR (n ¼ 6), no pregnancy was achieved in the subsequent cycle. Proteomic analysis was performed using DIGE. Samples were labelled using dye-switching combined in pairs: R versus NR as indicated in Table II were identified based on mass spectrometry analysis and validated using western blots and immunohistochemistry. Finally, natural cycle endometrial samples from donors (n ¼ 8) were obtained to verify the down-regulation of progesterone receptor membrane component 1 (PGRMC1) during the WOI in a fertile population.
Patients
This project was approved by the IVI investigation review board (1203-C-101-FD). Endometrial samples were obtained after signed written consent from the patients. We recruited patients until we obtained six R and six NR ERA-diagnosed endometria samples (ERA-R and ERA-NR, respectively). In total, 30 patients were recruited for the study but only six R and six NR endometria were used for the proteomic study due to the limitations of the DIGE technology (samples have to be analysed in pairs) and the imbalance between the R and NR results ( 75% endometrial samples resulted in R endometria; Ruiz-Alonso et al., 2013) . Endometrial biopsies were collected from the uterine fundus using a Pipelle catheter from Cornier Devices (CCD Laboratories) under sterile conditions after 5 days of progesterone treatment during a hormone replacement therapy (HRT) cycle. First, patients were primed with E2 administration (estradiol valerate; 6 mg a day) leading to the formation of a trilaminar endometrium of at least 7 mm depth. Then 800 mg of micronized vaginal progesterone (P) was given for 5 days (120 h). After sample collection, one-third of the endometrial sample was transferred to a cryotube containing 1 ml of RNAlater (Qiagen), vigorously shaken for a few seconds, and kept at 48C until the ERA microarray was performed. Another third was separated, fixed in formalin and was paraffin embedded for IHC studies. The last fragment was dry frozen at 2808C and stored for protein extraction later. Additionally, eight endometrial samples were taken from donors in their natural cycles: four obtained at 2 days after the peak in luteinizing hormone (LH+2; pre-receptive stage) and four 7 days after this peak (LH+7; receptive stage) to confirm the biological significance of PGRMC1 expression in a fertile sample cohort.
Transcriptomic analysis
Sample labelling and microarray hybridization Total RNA was extracted using Trizol (Life Technologies) according to the manufacturer's recommendations. RNA quality was assessed by loading 300 ng of total RNA onto an RNA Labchip and analysing it in an A2100 Bioanalyzer (Agilent Technologies). Good-quality RNA samples with an RNA integrity number greater than seven are a prerequisite for ERA analysis. Sample preparation and hybridization was adapted from the Agilent technical manual. In short, first-strand cDNA was transcribed from 200 ng total RNA using T7-Oligo(dT) promoter primers. Samples were transcribed in vitro and Cy-3 labelled with the Low Input Quick Amp Labelling kit (Agilent Technologies). The labelling reaction typically yielded 4 -5 mg of complementary RNA (cRNA) with a specific activity greater than six. Fragmented cRNA samples were hybridized onto the customized ERA array , by incubating it at 658C for 17 h with constant rotation. The microarray was then washed in two 1-min steps in two washing buffers (Agilent Technologies). Hybridized microarrays were scanned in an Axon 4100A scanner (Molecular Devices), and the data were extracted with Genepix Pro 6.0 software (Molecular Devices).
Endometrial receptivity array class prediction
ERA gene expression values were pre-processed and normalized and the endometrial receptivity status was diagnosed by the ERA computational predictor . The ERA test diagnoses the endometrial samples as R (receptive) or NR (non-receptive) with an associated diagnostic probability (see Table I ).
Proteomic analysis
Two-dimensional-differential in-gel electrophoresis sample preparation
Proteins from endometrial biopsy fragments were directly extracted in Lysis Buffer (7 M urea, 2 M thiourea, 4% CHAPS, 30 mM Tris-pH 8.5, and 1× complete protease inhibitor cocktail; Roche) using the 2D Grinding Kit (GE Healthcare, Chalfont, St Giles, UK). The suspension was shaken for 40 min at 158C and then centrifuged at 16 000 g for 15 min. Interfering components were removed using the 2D Clean Up Kit (GE Healthcare), and proteins were resuspended in Lysis Buffer. The protein concentration was determined using the RD/DC Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA).
Two-dimensional-differential in-gel electrophoresis separation
Proteins were labelled according to the manufacturer's protocol (GE Healthcare). Briefly, 50 mg of pre-receptive and receptive endometrial protein extracts were labelled with 400 pmol of the N-hydroxysuccinimide esters of Cy3 or Cy5 fluorescent cyanine dyes on ice in the dark for 30 min. An internal standard, containing equal amounts of each cell lysate, was labelled with Cy2 fluorescent dye and used for all the experiments. To avoid labelling bias arising from the fluorescence properties of gels at different wavelengths, protein extracts were labelled using dye-switching with either Cy3 or Cy5 fluorescent dyes. Each Cy3/Cy5-labelled sample pair was then mixed with a Cy2-labelled internal standard for each gel.
The labelling reaction was quenched with 1 ml of 10 mM lysine on ice for 10 min in the dark. The R and NR endometrial protein extracts and the internal standard protein samples were combined in pairs as shown in Table II and run in a single gel (150 mg total protein). Protein extracts were diluted 1:1 in 2× Sample Buffer (7 M urea, 2 M thiourea, 4% CHAPS, 1% DTT, and 1% IPG buffer 3 -11 NL) to incorporate reducing agents and ampholytes. The final sample volume was adjusted to 450 ml in Rehydration Buffer (7 M urea, 2 M thiourea, 4% CHAPS, and 1% IPG buffer 3 -11 NL), and applied by cup-loading to 24 cm IPG pH 3 -11 NL strips, which were previously rehydrated with Rehydration Buffer containing 100 mM hydroxyethyl disulfide (DeStreak, GE Healthcare), as previously described (Cortó n et al., 2004) . The first dimension was run at 0.05 mA per IPG strip in the IPGphor II IEF System (GE Healthcare) with a voltage increase in four steps: 300 V for 4 h, a linear gradient to 1000 V in 6 h, a linear gradient to 8000 V in 3 h, and 8000 V until steady state (around 32 000 Vh). After the first dimension, strips were equilibrated in SDS Equilibration Buffer (75 mM Tris pH 8. 8, 6 M urea, 30% (v/v) Endometrial biopsies obtained 5 days after progesterone administration which were diagnosed as receptive (R) or non-receptive (NR), and an internal standard control are shown. Gels were loaded with paired samples according to the table.
Equilibration Buffer containing 2.5% (w/v) iodoacetamide for 15 min. The proteins were then separated on 12.5% Tris-glycine gels using an Ettan DaltSix device (GE Healthcare) at 258C until the tracking dye had migrated off the bottom of the gel.
Image acquisition and analysis
After SDS -PAGE, gels were scanned with a Typhoon 9400 scanner (GE Healthcare) at 100 mm resolution using the appropriate wavelengths and filters for Cy2, Cy3 and Cy5 dyes. Relative protein quantification of R and NR samples was performed using DeCyder software v 7.0 and the multivariate statistical module EDA (Extended Data Analysis) v 7.0 (GE Healthcare) in a stepped process. First, a differential in-gel analysis (DIA) module was used to co-detect three images of the gel (internal standard and two samples) to accurately measure the spot ratios of the Cy3 and Cy5 spot volumes referring to the standard Cy2 volume on each gel. Background subtraction, quantification and normalization were automatically applied with low experimental variation (DeCyder Differential Analysis Software User Manual, version 7.0; GE Healthcare, 2005). The images were then individually processed with the DIA module and were matched between gels with the biological variation analysis (BVA) module using the internal standard for gel-to-gel matching. The BVA revealed the differences between experimental groups across all the gels. Each difference was calculated as average ratios for each spot. The paired Student's t-test was used to compare the average ratios for each spot between R and NR subjects. P-values ,0.05 were considered significant. Clustering of the experimental groups was performed by PCA (principal component analysis) using an algorithm included in the EDA module (v 7.0).
In-gel trypsin digestion
Protein spots for which the DeCyder differential analysis software and the EDA showed a significantly altered expression levels between the two groups (R and NR) were selected for gel excision. Protein spots from silverstained gels were visually matched against DIGE images and manually excised from gels. Samples were digested with sequencing-grade trypsin (Promega) as described elsewhere (Shevchenko et al., 1996 (Shevchenko et al., , 2006 . The digestion mixture was dried in a vacuum centrifuge and then resuspended in 10 ml of 2% ACN and 0.1% TFA.
Mass spectrometry
Digested samples were analysed by peptide mass fingerprint (PMF) analysis (matrix-assisted laser desorption/ionization-time of flight/time of flight; MALDI-TOF-TOF) and remaining unidentified protein mixtures were analysed by liquid chromatography and tandem mass spectrometry (LC -MS/ MS) in a qTOF (quadruple time of flight) instrument. MALDI samples were prepared by mixing equal volumes of the digestion solution and a matrix solution composed of 0.5 g/l a-cyano-4-hydroxycinnamic acid (Bruker Daltonik) in 70% aqueous acetonitrile and 0.1% TFA. The resulting mixtures were deposited onto an ABSCiex MALDI plate and analysed in a 5800 MALDI TOF/TOF instrument (ABSciex) in the positive reflection mode (3000 shots every position). Five of the most intense precursors (according to the threshold criteria: 'minimum signal-to-noise': 10; 'minimum cluster area': 500; 'maximum precursor gap': 200 ppm; 'maximum fraction gap': 4) were selected for every position for the MS/MS analysis, and MS/MS data were acquired using the default 1 kV MS/MS method. The MS and MS/MS information was sent to be identified by the MASCOT software (v 2.3.02; Matrix Science) via the Protein Pilot (ABSciex).
LC -MS/MS analysis was performed by loading 5 ml of each sample digestion onto a trap column (NanoLC Column, 3 m C18-CL, 100 mm × 15 cm; Nikkyo) and desalting it with 0.1% TFA at 2 ml/min for 10 min. The peptides were then loaded onto an analytical column (LC Column, 3 m C18-CL, 75 mm × 12 cm, Nikkyo) and equilibrated in 5% acetonitrile 0.1% FA (formic acid). The peptides were eluted with a linear gradient of 5% A to 40% B for 30 min (A: 0.1% FA; B: ACN, 0.1% FA) at a flow rate of 300 nl/min. Peptides were analysed in a nanoESI qQTOF mass spectrometer (5600 TripleTOF, ABSCIEX). The tripleTOF was operated in informationdependent acquisition mode, in which a 0.25-s TOF MS scan from 350 to 1250 m/z was performed, followed by 0.05-s product-ion scans from 100 to 1500 m/z on the 50 most intense 2 -5 charged ions. The MS/MS information was sent to MASCOT (v. 2.3.02; Matrix Science) or to PARAGON software via the Protein Pilot (v. 4.5; ABSciex).
Database searches
The PMF database search was performed on Swiss-Prot. Searches were done with a tryptic specificity allowing one missed cleavage and a tolerance on the mass measurement of 100 ppm in MS mode and 0.8 Da for MS/MS ions. Carbamidomethylation of Cys was used as a fixed modification and oxidation of Met and deamidation of Asn and Gln were set as variable modifications. Proteins showing a score higher than the homology or significance threshold were identified with a confidence of 95% or more. The protein score in the result report from an MS/MS search is derived from the ion scores. Protein mixtures unidentified by PMF were analysed by LC -MS/MS.
In silico analysis
GeneCards (http://www.genecards.org) were used to compare proteomic biomarker gene symbols to transcriptomic gene symbols. Functional enrichment, which gives a statistical approach to defining which genes belong to different GO categories, was performed with FatiGO (Al-Shahrour et al., 2007), a widely used SEA (serial expression analysis) implementation tool, which is included in the Babelomics web-based software package (Medina et al., 2010) . We used FatiGO with the gene ontology (GO; Ashburner et al., 2000) and KEGG pathway (Kanehisa et al., 2010) vocabularies and with the GO Slim option set to 'summarized'; GO Slims are reduced versions of the GO ontologies which contain a subset of the terms in the whole GO library. They give a broad overview of the ontology content, without the specific fine-grain details of the GO terms, which is particularly useful for summarizing the GO annotation (GOA) results. We used all 33 GO Slim GOA terms and so we did not need to select a level of analysis.
Network analysis was performed using GeneMania (Warde-Farley et al., 2010) a web tool that finds other genes which are related to a set of input genes, using a very large set of functional association data, including protein and genetic interactions, pathway, co-expression, and co-localization data, and protein domain similarities.
Comparison of proteomics and transcriptomics, functional enrichment, and network analysis
We used FatiGO to functionally enrich the proteomics and transcriptomics gene lists by comparing them to each other, and each of them to the complete genome. An adjusted P-value of ,0.05 was used as a statistical cut off for significant terms in all the comparisons. Statistically significant terms in 'Biological Process' (BP), 'Molecular Function' (MF), and 'Cell Component' (CC) GO Slim GOA terms, as well as KEGG pathways were analysed. Network analysis using GeneMANIA was performed to establish connections between genes and to find relationships, new functions and related pathways between the proteins in our list.
Western blots
Total protein was extracted from endometrial samples as described above. Due to the lack of samples only four out of the six endometrial biopsies employed in the DIGE experiment were validated by western blot. The proteins were denatured for 5 min at 958C and 40 mg was separated by discontinuous electrophoresis (stacking gel 4% polyacrylamide and resolving gel 10% polyacrylamide) for 1 h at 180 V. Proteins were then transferred onto a polyvinylidene difluoride (PVDF) membrane by wet electroblotting using Tris/Glycine transfer buffer (Biorad). The transfer conditions were 160 V for 4 h at 48C with shaking. Non-fat milk (5%) was used to block the PVDF membrane at RT for 1 h. The membranes were then incubated with primary anti-human PGRMC1 mouse monoclonal antibody (1:1000 dilution; Santa Cruz Biotechnology, Texas, USA) or anti-human annexin 6 (ANXA6) rabbit polyclonal antibody (1 mg/mL; Abcam, Cambridge, UK) at 48C overnight. After this, the membranes were incubated with polyclonal goat antimouse/rabbit IgG-HRP (1:2000 dilution; DakoCytomation, CA, USA) at RT for 1 h. PVDF membranes were analysed with an ECL Western Blotting Analysis System (GE Healthcare, Freiburg, Germany) and were photographed using Fujifilm LAS-300, and subsequent band densitometry analysis was performed with the Fujifilm Multi Gauge V3.0 program. Membranes were then stripped and incubated with monoclonal mouse anti-human b-Actin antibody (1:2000; Santa Cruz Biotechnology) and processed as described above.
Immunohistochemistry
Five formalin-fixed and paraffin-embedded endometrial biopsies were obtained after 5 days of progesterone administration from ERA-R and ERA-NR patients and were sectioned and mounted on glass slides coated with Vectabond TM (Vector Lab, Burlingame, CA, USA). Twelve serial sections (5 mm) from each sample were prepared, and the first and last sections were stained with haematoxylin-eosin. After deparaffinisation and rehydration, sections were rinsed three times with PBS for 5 min. Immunohistochemistry was performed on endometrial sections using the LSAB Peroxidase Kit (DAKO, CA, USA). The samples were previously treated with a heat-induced antigen retrieval solution with citrate buffer at pH 6.0; nonspecific binding was blocked with 5% BSA. Sections were incubated for 1 h at RT with mouse monoclonal anti-human PGRMC1 (Santa Cruz Biotechnology) or rabbit polyclonal ANXA6 (Abcam), both diluted in PBS with 3% BSA at a 1:50 dilution.
We included negative controls (incubated with PBS and 3% BSA in the absence of primary antibodies) and positive control tissues (human liver). Secondary antibodies were included in the LSAB Peroxidase Kit (DAKO) and are valid for primary rabbit, mouse or goat antibodies. DAB chromogen staining was achieved by immersing the slides for 30 s to 1 min in DAB solution. After counterstaining with haematoxylin for 10 s and washing with distilled water, slides were mounted with Entellan w (Merck, Darmstadt Germany). H-Scores were calculated by three independent observers (F.D., A.Q. and T.G.-G.), and ranged between the absence of staining (0) to a very strong signal (3). H-Score values, means and SEs for each of the locations studied (luminal epithelium, glandular epithelium and stromal cells) were calculated using the R statistical package (http://www.r-project.org/).
Statistical analysis
Relative protein quantification of R and NR samples was performed using DeCyder software v 7.0 and the multivariate statistical module EDA (Extended Data Analysis) v 7.0 (GE Healthcare) in a stepped process. The paired Student's t-test was used to compare the average ratios for each spot between R and NR subjects. P-values ,0.05 were considered significant. Clustering of the experimental groups was performed by PCA (principal component analysis) using an algorithm included in the EDA module (v 7.0). Figure 1 Two-dimensional-differential in-gel electrophoresis (DIGE) separation of endometrial proteins. Individual proteins from receptive and nonreceptive endometrial receptivity array (ERA)-diagnosed endometria (ERA-R and ERA-NR, respectively) and a pooled internal standard were labelled with Cy3, Cy5 and Cy2 dyes, respectively (left to right), and were mixed and separated on a 2D gel using 24 cm pH 3 -11 NL strips in the first dimension, and 10% PAGE-SDS gels in the second dimension. Gels were scanned to obtain single images of R proteins (Cy3, green; A), NR proteins (Cy5, red; B), or the internal standard (Cy2, blue; C). An overlay of the two dyes (Cy3 and Cy5; D) is shown (Merge). After fluorescence imaging, the same gel was silver-stained and scanned (Silver; E). Western blot densitometry statistical analysis was performed with a Student's t-test using SPSS v.17.
Results
DIGE analysis and protein identification by MALDI mass spectrometry in receptive versus non-receptive array-diagnosed endometrial samples
The DIGE analysis was performed on twelve endometrial samples combined in pairs (R versus NR) as indicated in Table II . After the 2D electrophoresis, the Cy2, Cy3 and Cy5 channels were individually imaged from each gel (Fig. 1A -C) . Spot detection with the DIA module identified 37 statistically significant differentially expressed spots, present in at least five of the six gels analysed, which were excised from the gels and identified by MALDI-MS ( Fig. 1D-E) ; of these, nine proteins were up-regulated and fifteen were down-regulated in the NR versus the R endometria (Table III) .
Functional enrichment and network analysis of endometrial receptivity proteomics and transcriptomics lists
First, we analysed if the deregulated ERA-R versus ERA-NR proteomic signature corresponded to its transcriptomic counterpart by crosschecking the protein and gene lists. Surprisingly, the 238 genes present in the ERA did not directly coincide with the 24 deregulated proteins we found. Similarly, no common significant terms were revealed when using additional functional enrichment analysis, although two differences in 'glycolysis processes' and 'catalytic and lyase activity' were identified. Although no direct or indirect relationships were found between the transcriptomic and proteomic signatures, we focused on the proteomic signature of endometrial receptivity. We used GeneMANIA software to create a relationship network between these 24 deregulated proteins, also including 20 link nodes not directly found in our proteomic study but which could help us to understand the different pathways implicated in endometrial receptivity (Fig. 2) . Analysis of this network highlighted two statistically significant pathways: the 'carbohydrate biosynthetic process' and 'nuclear mRNA splicing via spliceosome'. Figure 2 Proteomic network of deregulated proteins between receptive and non-receptive endometria diagnosed by endometrial receptivity array. All proteins are represented by their gene symbol name. Different colour lines connecting proteins represent the relationships between them (physical interaction, co-expression, co-localization, shared and predicted protein domains). Spheres represent proteins obtained in our proteomic study while squares represent link nodes between them. Two statistically significant pathways were identified in the network: proteins integrated in the 'carbohydrate biosynthetic process' are represented in orange while proteins related to 'nuclear mRNA splicing via spliceosome' are represented in orange. Gene symbols for each protein can be found on Table III .
Validation of differential in-gel electrophoresis results by western blot
To validate the differences in protein expression shown by DIGE, we used the same samples for western blots for ANXA6 and PGRMC1, observing similar expression between the two: a significant 2.6-fold PGRMC1 down-regulation (Fig. 3A -B) and a significant 2.7-fold ANXA6 down-regulation (Fig. 3C -D) in ERA-R versus ERA-NR endometrial samples. We analysed an additional eight natural cycle endometrial biopsies from different women throughout the menstrual cycle to confirm PGRMC1 down-regulation during the receptive state (Fig. 3E) . There was significantly less PGRMC1 present in mid-secretory (WOI) than in pre-WOI (early-secretory phase) endometrial samples (Fig. 3F) . We also observed very low levels of this protein in the early-proliferative phase.
Immunolocalization of progesterone receptor membrane component 1 and annexin A6 in receptive and non-receptive endometrial receptivity array-diagnosed endometria Because ANXA6 and PGRMC1 seemed to be important in the acquisition of endometrial receptivity and are both proteins found in our DIGE Figure 3 Validation of progesterone receptor membrane component 1 and annexin A6 by western blot. Bands corresponding to 30 kDa for progesterone receptor membrane component 1 (PGRMC1; A) and 76 kDa for annexin A6 (ANXA6; C) were analysed by western blot in 8 of the 12 DIGE analysed endometrial samples. Densitometric analysis showed similar results to the DIGE analysis (B and D). PGRMC1 was also analysed by western blot in eight endometrial natural cycle samples from eight different donors to test its biological significance outside the sample cohort (E). Densitometric analysis of PGRMC1 band intensity throughout the menstrual cycle showed a significant decrease in the mid-secretory (window of implantation) phase (F). * corresponds to P-value ,0.005; ** corresponds to P-value ,0.001. P: proliferative phase; ES, MS, LS: early, mid-and late secretory phase, respectively. R: receptive and NR: non-receptive endometrium as diagnosed by ERA: endometrial receptivity array. experiment, we decided to localize these proteins in human endometrium diagnosed with our ERA tool after 5 days of progesterone administration. The abundance ANXA6 protein was increased in ERA-NR endometrium, showing a very strong staining signal in the stromal compartment with some light staining also present in the luminal and glandular epithelia (Fig. 4A, B and G) . A fainter signal was observed in the stromal compartment of ERA-R endometrium but was only present in the apical part of the luminal epithelium (Fig. 4C, D and G) . PGRMC1 showed intense staining in ERA-NR samples in both the glandular and luminal epithelium and in endometrial stromal cells (Fig. 4H, I and N) . Staining was strongly reduced in ERA-R endometrium, particularly in the stromal cell compartment, and there was patchier staining pattern in the luminal and glandular epithelium (Fig. 4J, K and N) .
Discussion
Although previous studies have described the differential proteomic pattern of the receptive endometrium in natural and HRT cycles (DeSouza et al., 2005; Dominguez et al., 2009; Parmar et al., 2009; Hannan et al., 2010) , none of them have used the molecular diagnosis of the receptivity status in samples obtained on the same HRT-cycle day as a gold standard. To compare and quantify the expression profiles Figure 4 Immunolocalization of annexin A6 and progesterone receptor membrane component 1 in the receptive and non-receptive endometrium diagnosed by the endometrial receptivity array. Immunoreactivity to ANXA6 (A-F) and PGRMC1 (H-M) in ERA-R and ERA-NR human endometria, 5 days after progesterone administration, in positive tissue (liver) and negative controls are shown. Formalin-fixed and paraffin-embedded ERA-R and ERA-NR human endometrial biopsies (n ¼ 5) were H-Score assessed by three independent observers for staining signals, rated 0 (absent), 1 (weak signal), 2 (strong signal) or 3 (very strong signal). The mean scores are presented in the scatter plots as horizontal bars (G and N). Strong ANXA6 staining was observed in the stromal compartment and glandular epithelium in the NR endometrium (A: ×20 and B: ×40 magnification, respectively), while clear but lighter staining was observed throughout the tissue in the R endometrium (C: ×20 and D: ×40 magnification, respectively). Strong staining was detected in the liver (E: ×40 magnification), and no signal was observed in the negative control (F: ×20 magnification). Mean ANXA6 H-Score (G). Very Strong PGRMC1 staining was present in stromal cells and in the apical part of the glandular epithelium in the NR endometrium (H and I: ×40 magnification), while there were some patches of staining in glandular and luminal epithelial cells, and almost no staining in stromal cells in the R endometrium (J and K: ×40 magnification). Strong staining was detected in the liver (L: ×40 magnification). No signal was observed in negative control (M). Mean PGRMC1 H-Score (N).
of complex protein mixtures, the most widely used method is DIGE (Unlu et al., 1997) which is based on labelling samples with spectrally different fluorescent Cy2, Cy3 or Cy5 dyes (Alban et al., 2003; Knowles et al., 2003) . We used DIGE to identify 24 statistically significant deregulated proteins by comparing ERA-R and ERA-NR endometrial samples taken after 5 days of progesterone administration. These data were highly reproducible (with similar expression patterns in at least five out of six gels) although the variation found was low (1.2-to 2.0-fold change differences).
We created a network with these 24 proteins along with several introduced nodes in order to determine if any pathway or group of proteins was involved in the differential receptiveness status, and identified two statistically significant pathways comparing the ERA-R and ERA-NR endometria: 'carbohydrate biosynthetic process' and 'nuclear mRNA splicing via spliceosome'. This network highlighted phosphoglucomutase 1 (PGM1), alpha enolase (ENO1) and sialic acid synthase (SIAS) as deregulated proteins related to carbohydrate metabolism pathways which might be implicated in changing the metabolic status of the endometrium towards a receptive stage. We also identified heterogeneous nuclear ribonucleoprotein L (HNRPL) and serine/arginine-rich splicing factor 3 (SRSF3) which are both nuclear proteins involved in RNA processing in relation to cellular proliferation and/or maturation. The proteomics of the acquisition of endometrial receptivity is not yet well studied, but it is likely that many splicing variants of hundreds of genes take part in this complex process, and so slight changes in the concentration of these proteins could dramatically alter epithelial/stromal cell mRNA splicing patterns. Although we are aware that no clear correlation between transcriptomics and proteomics analyses is usually found (Hegde et al., 2003; Chen et al., 2007) , we were surprised by the complete absence (both directly or via pathways and GO terms) of correlation between the 238 genes related to the acquisition of endometrial receptivity and the 24 deregulated proteins detected in the same endometrial samples. We attributed these findings to the intrinsic limitations of the DIGE technique which precludes the analysis of proteins outside the range of the pH 3 -11 strip used as well as very large or small species, hydrophobic, or low-abundance proteins. Additionally, most secreted proteins were not present in the endometrial biopsies used, and moreover, post-transcriptional protein modifications might have further contributed to this loss. Obviously, no single approach can fully unravel the complexities of fundamental biology and it is also apparent that integrative analysis of multiple levels of gene expression would be valuable in this endeavour (Nie et al., 2006) . It is also important to consider that the original ERA gene cohort (Díaz-Gimeno et al., 2011) was selected based on a .3-fold change threshold with genes which are differentially expressed between pre-receptive versus receptive samples.
Our DIGE analysis results were validated by western blots and immunohistochemistry using two proteins: ANXA6 and PGRMC1. We confirmed increased ANXA6 expression and PGRMC1 up-regulation in ERA-NR versus ERA-R endometrial samples. Furthermore, when we studied PGRMC1 expression in the natural cycle of fertile patients, we observed a similar sharp down-regulation during the WOI. Annexins take part in the rearrangement of the cytoskeleton (Thie et al., 1997) , destabilization of apico-basal polarity and redistribution of different molecules in endometrial epithelial cells (Lindenberg, 1991) . In our previous proteomic study, we identified annexin A2 (ANXA2) as an important cytoskeletal marker in the receptive human endometrium (Dominguez et al., 2009 ) with intense stromal cell expression. This may implicate ANXA2 in regulation of the decidualization process, which requires actin cytoskeleton reorganization (Ihnatovych et al., 2009) . We also selected PGRMC1 for validation because of its important role as a quick response progesterone receptor (Wu et al., 2011) . Not all the effects of the progesterone can be explained by the classical model of steroid action and, like all steroid hormones, progesterone exerts rapid effects on diverse signalling pathways independently of transcriptional or genomic regulation (Falkenstein et al., 1998; Schmidt et al., 2000; Losel and Wehling, 2003) . This is the first time that ANXA6 or PGRMC1 expression has been associated with human endometrial receptivity, but in the light of the evidence discussed above, we consider them to be important candidates for further study in this field.
Our findings also suggest that although histological dating may indicate a 'receptive' status within the traditional WOI, a different transcriptomic and proteomic profile is observed in these samples. This means that sample selection based on histological dating may create bias in studies trying to define or understand the molecular mechanisms of endometrial receptivity acquisition. We are now moving towards using more personalized WOIs by diagnosing endometrial receptivity status based on an individual's specific endometrial molecular signature, thereby improving the success of IVF treatments. In conclusion, this descriptive study investigated the differential proteomic signature of same-day endometria, diagnosed as receptive or non-receptive during the implantation window using a molecular tool. We point towards ANXA6 and PGRMC1 as individual new targets and to 'carbohydrate biosynthetic process' and 'nuclear mRNA splicing via spliceosome' as important pathways related to the acquisition of endometrial receptivity.
